BioDEpi
Skin epidermis model for toxicity testing
CommercialLaunched December 2021
Key Facts
Indication
Skin epidermis model for toxicity testing
Phase
Commercial
Status
Launched December 2021
Company
About Biodimension
Biodimension engineers biofabricated human tissues and organoids to replace animal testing and accelerate drug discovery with human-relevant data.
View full company profile